Where we at?, page-414

I agree with you tbqh Weazel, but i'm opening my mind a little to 2x2 creating a bump of some sort simply because how connected it now is to non-dilutive funding. However, my read is that the recent (opaque) guidance around a response timeframe from the FDA on 2x2 paves the way for a CR first. The rubicon of their financial indiscipline has always been raising before they are down to a couple of quarters of cash - and despite being financially cavalier they have not crossed this yet. Therefore, i'm expecting a CR before non-dilutive funds are proximate enough to be relied upon. Just my read. If i'm wrong it won't be the first or last time.